These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 1019161)

  • 1. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal relation between renin dependency and sodium dependency in essential hypertension.
    Gavras H; Ribeiro AB; Gavras I; Brunner HR
    N Engl J Med; 1976 Dec; 295(23):1278-83. PubMed ID: 980059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
    Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II blockade in hypertensive dialysis patients.
    MacGregor GA; Dawes PM
    Prog Biochem Pharmacol; 1976; 12():190-9. PubMed ID: 1019164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys.
    Linas SL; Miller PD; McDonald KM; Stables DP; Katz F; Weil R; Schrier RW
    N Engl J Med; 1978 Jun; 298(26):1440-4. PubMed ID: 349389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II blockade in normal man: interaction of renin and sodium in maintaining blood pressure.
    Posternak L; Brunner HR; Gavras H; Brunner DB
    Kidney Int; 1977 Mar; 11(3):197-203. PubMed ID: 846071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
    Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
    Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
    Pagny JY; Thibonnier M; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S82-5. PubMed ID: 2412019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
    Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ
    J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of renin in the control of blood pressure in normotensive man.
    Mulrow PJ; Noth R
    Prog Biochem Pharmacol; 1976; 12():163-9. PubMed ID: 1019162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery.
    Romero JC; Holmes DR; Strong CG
    Circ Res; 1977 May; 40(5 Suppl 1):I17-23. PubMed ID: 870227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

  • 20. [Saralasin and prediction of the surgical result in renovascular arterial hypertension].
    Mimran A; Deschodt G; Fourcade J; Barjon P
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():16-21. PubMed ID: 119507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.